Conexeu Sciences Inc. (NASDAQ: CNXU) is a Healthcare company (Biotechnology) with a market capitalization of $62M. The Maz Rating grades it against the other companies in its sector.
Conexeu Sciences Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
Over the past 52 weeks the share price ranged from $1.93 to $18.79, with a beta of 0.51.
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Not yet. Conexeu Sciences Inc. (CNXU) cannot be screened by Maz Vantage: not enough of its balance sheet is available.
Not yet. Conexeu Sciences Inc. (CNXU) cannot be screened by Maz Vantage: not enough of its balance sheet is available.
The screen is rerun on each quarterly report. A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.